Results 41 to 50 of about 17,968 (263)
Vulvar Sweat Gland Carcinomas
Journal of Urology, 1985 Sweat gland carcinomas constitute less than 10% of all malignant tumors of the vulva, including those associated with extramammary Paget's disease (EPD). The histopathologic diagnosis of vulvar sweat gland carcinomas is difficult because of their rarity; their resemblance to metastatic carcinomas of the internal female genitalia, kidneys, and other ...John R. Goellner, W.P.D. Su, M.R. Wick, James T. Wolfe +3 moreopenaire +3 more sourcesAn Unexpected Complete Remission of Advanced Intestinal-Type Vulvar Adenocarcinoma after Neoadjuvant Chemotherapy: A Case Report and a Literature Review
Case Reports in Obstetrics and Gynecology, 2013 Vulvar cancer represents approximately 3%–5% of all gynecological malignancies. Squamous cell carcinoma is the most frequent histotype, whereas melanomas, adenocarcinomas, basal cell carcinomas, and sarcomas are much less common.Angela Musella, Claudia Marchetti, Laura Salerno, Laura Vertechy, Roberta Iadarola, Irene Pecorella, Pierluigi Benedetti Panici +6 moredoaj +1 more sourceVulvar Merkel Carcinoma: A Case Report [PDF]
Case Reports in Medicine, 2011 This is a new case of Merkel cell carcinoma of the vulva. It is a rare neuroendocrine carcinoma with an aggressive behavior. Because of its rarity in this location, it is not clear whether it behaves differently from the usual neuroendocrine carcinomas of the skin. A case of a 63-year-old patient with vulvar Merkel carcinoma is presented.V. Dertimas, Christos Iavazzo, M. Terzi, P. Arapantoni-Dadioti, G. Vorgias +4 moreopenaire +4 more sourcesDermoscopic and reflectance confocal microscopy features of two cases of vulvar basal cell carcinoma [PDF]
, 2018 Basal cell carcinoma (BCC) is the most common malignant skin cancer. Its genital localization is rare, and the diagnosis in this site could be challenging.Cinotti, Elisa, Habougit, Cyril, Luisi, Stefano, Perrot, Jean Luc, Rubegni, Pietro, Tonini, Giulia +5 morecore +2 more sourcesCancer incidence in people with HIV in Italy: Comparison of the ICONA COHORT with general population data
International Journal of Cancer, Volume 157, Issue 6, Page 1142-1153, 15 September 2025.What's new?
Immune suppression induced by HIV infection significantly increases the risk of certain cancers among people with HIV (PWH). In the present study, the authors investigated cancer incidence among HIV‐infected individuals in Italy using data from the Italian Cohort Naïve Antiretrovirals. Comparison with the corresponding general population in Pierluca Piselli, Alessandro Tavelli, Claudia Cimaglia, Camilla Muccini, Alessandra Bandera, Giulia C. Marchetti, Carlo Torti, Valentina Mazzotta, Luca Pipitò, Alessandro Caioli, Enrico Girardi, Andrea Antinori, Diego Serraino, Antonella d'Arminio Monforte, Antonella Cingolani, Icona Foundation Study Group, A d'Arminio Monforte, A Antinori, S Antinori, A Castagna, R Cauda, G Di Perri, E Girardi, R Iardino, A Lazzarin, GC Marchetti, C Mussini, E Quiros‐Roldan, L Sarmati, B Suligoi, F von Schloesser, P Viale, A d'Arminio Monforte, A Antinori, A Castagna, F Ceccherini‐Silberstein, A Cingolani, A Cozzi‐Lepri, A Di Biagio, E Girardi, A Gori, S Lo Caputo, G Marchetti, F Maggiolo, C Mussini, M Puoti, CF Perno, C Torti, A Antinori, A Bandera, S Bonora, A Calcagno, D Canetti, A Castagna, F Ceccherini‐Silberstein, A Cervo, A Cingolani, P Cinque, A Cozzi‐Lepri, A d'Arminio Monforte, A Di Biagio, R Gagliardini, A Giacomelli, E Girardi, N Gianotti, A Gori, G Guaraldi, S Lanini, G Lapadula, M Lichtner, A Lai, S Lo Caputo, G Madeddu, F Maggiolo, V Malagnino, G Marchetti, A Mondi, V Mazzotta, C Mussini, S Nozza, CF Perno, S Piconi, C Pinnetti, M Puoti, E Quiros Roldan, R Rossotti, S Rusconi, MM Santoro, A Saracino, L Sarmati, V Spagnuolo, N Squillace, V Svicher, L Taramasso, C Torti, A Vergori, A Cozzi‐Lepri, S De Benedittis, I Fanti, M Giotta, C Marelli, A Rodano, A Tavelli, M Cernuschi, L Cosmaro, A Perziano, V Calvino, D Russo, M Farinella, N Policek, VL Del Negro, M Augello, S Carrara, S Graziano, G Prota, S Truffa, D Vincenti, R Rovito, M Sgarlata, Italy A Giacometti, A Costantini, V Barocci, A Saracino, C Santoro, E Milano, L Comi, C Suardi, P Viale, L Badia, S Cretella, EM Erne, A Pieri, E Quiros Roldan, E Focà, B Menzaghi, C Abeli, L Chessa, F Pes, P Maggi, L Alessio, G Nunnari, BM Celesia, J Vecchiet, K Falasca, A Pan, S Dal Zoppo, D Segala, F Bartalesi, A Bartoloni, B Borchi, C Costa, S Lo Caputo, S Ferrara, M Bassetti, E Pontali, S Blanchi, N Bobbio, C. Del Borgo, R. Marocco, G. Mancarella, S Piconi, C Molteni, S Rusconi, G Canavesi, G Pellicanò, G Marchetti, S Antinori, A Gori, M Puoti, A Castagna, A Bandera, V Bono, MV Cossu, A Giacomelli, R Lolatto, MC Moioli, L Pezzati, S Diotallevi, C Tincati, C Mussini, M Menozzi, P Bonfanti, G Lapadula, V Sangiovanni, I Gentile, V Esposito, N Coppola, FM Fusco, G Di Filippo, V Rizzo, N Sangiovanni, S Martini, AM Cattelan, D Leoni, A Cascio, M Trizzino, D Francisci, E Schiaroli, G Parruti, F Sozio, D Messeri, SI Bonelli, C Lazzaretti, R Corsini, A Antinori, R Cauda, C Mastroianni, L Sarmati, A Latini, A Cingolani, I Mastrorosa, S Lamonica, M Capozzi, M Camici, I Mezzaroma, M Rivano Capparuccia, G Iaiani, C Stingone, L Gianserra, J Paulicelli, MM Plazzi, G d'Ettore, M Fusto, M Lichtner, I Coledan, G Madeddu, A De Vito, M Fabbiani, F Montagnani, A Franco, R Fontana Del Vecchio, D Francisci, C Di Giuli, GC Orofino, G Calleri, G Di Perri, S Bonora, G Accardo, C Tascini, A Londero, G Battagin, S Nicolè, G Starnini, S Dell'Isola +243 morewiley +1 more sourceRandomised trial on treatment of vaginal high‐grade squamous intraepithelial lesion: Self‐administered vaginal imiquimod and laser vaporisation
International Journal of Cancer, EarlyView.What's New?
Vaginal high‐grade squamous intraepithelial lesions (HSILs), precursors of vaginal cancer that are related to human papillomavirus (HPV) infection, often are treated with laser vaporization. HSIL treated in this way, however, tends to recur.Mari Kiviharju, Annika Riska, Ilkka Kalliala, Maija Jakobsson, Annu Heinonen, Joakim Dillner, Pekka Nieminen, Karoliina Aro +7 morewiley +1 more sourcePrognostic impact of p16 and high‐risk HPV DNA in ~1300 patients with vulvar cancer
International Journal of Cancer, EarlyView.What's New?
Vulvar cancer (VSCC) is rare, and little is known about early prognostic factors that could contribute to an individualized treatment plan. About 30%–40% of VSCCs are associated with human papillomavirus (HPV). Here, the authors investigated the prognostic influence of p16 status in VSCC in a large cohort of 1300 patients.Susanne K. Kjær, Kirsten Frederiksen, Christina L. Rasmussen, Louise T. Thomsen, Else M. Madsen, Maria B. Franzmann, Alexander K. Kjær, Lise G. Larsen, Nadia V. Salinas, Doris Schledermann, Birgitte H. Winberg, Pernille T. Jensen, Dorthe Ørnskov, Marianne Waldstrøm, Louise Baandrup +14 morewiley +1 more sourceUnderstanding delays in breast cancer diagnosis in Africa: Key insights and contributing factors
International Journal of Cancer, EarlyView.What's New?
Despite lower incidence rates, Africa has the highest age‐standardized breast cancer mortality rates globally. Using Bronfenbrenner's ecological model to classify multilevel influences on the individual, this scoping review shows that a lack of knowledge about breast cancer is the primary factor contributing to breast cancer diagnostic ...Liza A. Hoveling, Lynn P. Heuken, Thachita Harfst, Melinda S. Schuurman, Kristel M. van Asselt, Sabine Siesling, Christina Bode +6 morewiley +1 more source